or Try an Advanced Search...

    Technical Analysis for NLSP - NLS Pharmaceutics Ltd.

    Grade Last Price % Change Price Change
    F 3.60 -0.83% -0.03
    NLSP closed down 0.83 percent on Friday, November 1, 2024, on 47 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical NLSP trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish -0.83%
    Older End-of-Day Signals for NLSP ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 18 hours ago
    Possible Inside Day about 18 hours ago
    60 Minute Opening Range Breakout about 19 hours ago
    60 Minute Opening Range Breakdown about 21 hours ago
    Rose Above Lower Bollinger Band about 22 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    NLSP Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of drug therapies to treat rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its two lead product candidates, include Quilience, for the treatment of excessive daytime sleepiness and cataplexy; and Nolazol, for the treatment of ADHD. NLS Pharmaceutics AG was founded in 2015 and is based in Stans, Switzerland.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Neurological Disorders Psychiatric Diagnosis Psychiatry Attention Deficit Hyperactivity Disorder Drug Therapies Sleep Disorders Narcolepsy Amphetamine Methylphenidate Adhd Cataplexy Idiopathic Hypersomnia

    Is NLSP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 28 NLS Pharmaceutics regains compliance with Nasdaq
    Oct 28 NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
    Oct 21 NLS Pharmaceutics Secures Key Patent in Japan for Mazindol ER in the Treatment of Heroin Dependence
    Oct 15 NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules
    Sep 25 NLS Pharmaceutics to conduct reverse share split
    Sep 25 NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split
    Jul 29 Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Jul 29 NLS Pharmaceutics Signs Binding Term Sheet for Merger With Kadimastem; Shares Rise
    Jul 29 NLS Pharmaceutics announces binding term sheet to merge with Kadimastem
    Jul 29 NLS Pharmaceutics and Kadimastem Announce Binding Term Sheet to Merge
    See more NLSP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 29.08
    52 Week Low 3.5101
    Average Volume 22,557
    200-Day Moving Average 8.43
    50-Day Moving Average 5.17
    20-Day Moving Average 4.55
    10-Day Moving Average 4.20
    Average True Range 0.51
    RSI (14) 28.06
    ADX 32.63
    +DI 10.23
    -DI 28.67
    Chandelier Exit (Long, 3 ATRs) 4.12
    Chandelier Exit (Short, 3 ATRs) 5.03
    Upper Bollinger Bands 5.59
    Lower Bollinger Band 3.51
    Percent B (%b) 0.04
    BandWidth 45.80
    MACD Line -0.42
    MACD Signal Line -0.34
    MACD Histogram -0.0815
    Fundamentals Value
    Market Cap 128.42 Million
    Num Shares 35.7 Million
    EPS -0.50
    Price-to-Earnings (P/E) Ratio -7.20
    Price-to-Sales 0.00
    Price-to-Book 4.84
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.98
    Resistance 3 (R3) 4.00 3.91 3.91
    Resistance 2 (R2) 3.91 3.81 3.89 3.89
    Resistance 1 (R1) 3.75 3.75 3.71 3.73 3.87
    Pivot Point 3.66 3.66 3.63 3.64 3.66
    Support 1 (S1) 3.50 3.56 3.46 3.48 3.33
    Support 2 (S2) 3.41 3.50 3.39 3.31
    Support 3 (S3) 3.25 3.41 3.29
    Support 4 (S4) 3.23